Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2026-01-01 @ 6:37 PM
Study NCT ID:
NCT04560569
Status:
UNKNOWN
Last Update Posted:
2021-09-29
First Post:
2020-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection
Sponsor:
Frontier Biotechnologies Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ABT-3BNC117_203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None